US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist

28.750
+0.450+1.59%

Close Jul 22 16:00 ET

3.57BMarket Cap-6796P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Mar 31, 2024

(Q1)Dec 31, 2023

(FY)Sep 30, 2023

(Q4)Sep 30, 2023

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

(FY)Sep 30, 2022

(Q4)Sep 30, 2022

(Q3)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-191.68%-92.38M

-56.05%-117.84M

-13.05%-153.89M

63.26%-25.26M

68.84%-21.45M

-150.49%-31.67M

-23.17%-75.52M

-179.46%-136.13M

-186.06%-68.74M

-132.40%-68.82M

Net income from continuing operations

-366.37%-127M

-223.78%-135.38M

-18.57%-209.28M

-29.17%-111.02M

-44.53%-104.13M

7.46%47.68M

33.50%-41.81M

-25.31%-176.49M

-35.61%-85.94M

-140.76%-72.05M

Operating gains losses

--0

---80K

----

359.48%4.43M

----

Depreciation and amortization

69.54%4.53M

58.53%4.26M

19.88%12.49M

45.08%3.86M

26.29%3.28M

2.89%2.67M

4.51%2.69M

26.06%10.42M

6.23%2.66M

29.89%2.59M

Other non cash items

43.27%7.25M

88.38%5.37M

--18.33M

--6.29M

145.13%4.13M

730.38%5.06M

1,117.50%2.85M

----

3,401.96%1.68M

Change In working capital

103.15%3.37M

81.67%-10.87M

47.56%-51.55M

517.88%59.44M

237.46%55.25M

-473.48%-106.91M

-135.10%-59.32M

-142.99%-98.29M

-688.78%-14.23M

-105.41%-40.19M

-Change in receivables

--0

-84.06%1.41M

206.40%1.25M

6,225.42%68.19M

-2,459.30%-29.87M

-477.61%-38.16M

194.01%8.85M

87.78%-1.17M

280.92%1.08M

-Change in prepaid assets

-109.15%-895K

-116.60%-1.75M

160.15%11.6M

-56.47%-16.31M

236.91%7.6M

441.60%9.78M

2,439.78%10.53M

-5,258.61%-19.29M

-511.20%-10.42M

-714.37%-5.55M

-Change in payables and accrued expense

132.18%3.64M

-29.97%-12.06M

61.57%18.03M

246.74%45.11M

3.06%-6.49M

-190.35%-11.32M

-20.78%-9.28M

-8.14%11.16M

374.49%13.01M

-141.46%-6.7M

-Change in other current liabilities

----

579.07%3.8M

----

143.04%559K

----

-Change in other working capital

105.89%4.42M

96.23%-866K

16.58%-82.59M

287.92%29.39M

50.58%-14.06M

-172.68%-74.95M

16.25%-22.98M

-143.75%-99.01M

-210.12%-15.64M

19.47%-28.44M

Cash from discontinued investing activities

Operating cash flow

-191.68%-92.38M

-56.05%-117.84M

-13.05%-153.89M

63.26%-25.26M

68.84%-21.45M

-150.49%-31.67M

-23.17%-75.52M

-179.46%-136.13M

-186.06%-68.74M

-132.40%-68.82M

Investing cash flow

Cash flow from continuing investing activities

-645.70%-268.94M

180.35%64.84M

-1,675.06%-96.16M

-16.29%30.51M

-116.16%-9.91M

48.30%-36.07M

-141.71%-80.69M

96.18%-5.42M

130.82%36.45M

413.59%61.28M

Net PPE purchase and sale

-24.75%-34.08M

-76.44%-68.66M

-234.88%-176.74M

-95.37%-63.91M

-388.73%-46.61M

-474.79%-27.31M

-573.43%-38.91M

-123.94%-52.78M

-298.96%-32.71M

-142.58%-9.54M

Net investment purchase and sale

-2,583.83%-234.86M

419.50%133.5M

70.15%80.58M

36.53%94.42M

-48.17%36.7M

86.54%-8.75M

-51.35%-41.78M

140.10%47.36M

162.84%69.16M

553.65%70.81M

Cash from discontinued investing activities

Investing cash flow

-645.70%-268.94M

180.35%64.84M

-1,675.06%-96.16M

-16.29%30.51M

-116.16%-9.91M

48.30%-36.07M

-141.71%-80.69M

96.18%-5.42M

130.82%36.45M

413.59%61.28M

Financing cash flow

Cash flow from continuing financing activities

82,741.73%430.78M

-99.89%267K

288.20%253.05M

-82.22%152K

-97.02%1.81M

-71.83%520K

13,193.16%250.58M

476.61%65.19M

4.91%855K

2,099.64%60.6M

Proceeds from stock option exercised by employees

190.77%1.51M

-53.65%267K

-41.13%3.05M

-3.98%821K

89.33%1.14M

-71.83%520K

-69.44%576K

-54.13%5.19M

4.91%855K

-78.22%600K

Net other financing activities

----

316.67%250M

---669K

--669K

--0

--250M

--60M

--0

----

Cash from discontinued financing activities

Financing cash flow

82,741.73%430.78M

-99.89%267K

288.20%253.05M

-82.22%152K

-97.02%1.81M

-71.83%520K

13,193.16%250.58M

476.61%65.19M

4.91%855K

2,099.64%60.6M

Net cash flow

Beginning cash position

-71.22%58.22M

2.67%110.89M

-41.44%108.01M

-24.46%105.33M

56.19%134.96M

120.83%202.25M

-41.44%108.01M

28.45%184.43M

-57.22%139.44M

-76.80%86.41M

Current changes in cash

203.34%69.46M

-155.88%-52.73M

103.94%3.01M

117.19%5.4M

-155.68%-29.55M

-1,197.61%-67.22M

201.68%94.37M

-286.53%-76.36M

77.78%-31.44M

214.37%53.06M

Effect of exchange rate changes

135.14%26K

147.54%58K

-82.09%-122K

5,000.00%153K

-146.88%-79K

-7,500.00%-74K

-212.82%-122K

23.86%-67K

--3K

---32K

End cash Position

-5.38%127.7M

-71.22%58.22M

2.67%110.89M

-24.46%105.33M

56.19%134.96M

120.83%202.25M

-41.44%108.01M

-57.22%139.44M

Free cash flow

-114.38%-126.45M

-62.98%-186.5M

-75.02%-330.63M

12.11%-89.16M

13.15%-68.05M

-201.74%-58.99M

-70.57%-114.43M

-227.86%-188.91M

-214.78%-101.45M

-133.60%-78.35M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Mar 31, 2024	(Q1)Dec 31, 2023	(FY)Sep 30, 2023	(Q4)Sep 30, 2023	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022	(FY)Sep 30, 2022	(Q4)Sep 30, 2022	(Q3)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-191.68%-92.38M	-56.05%-117.84M	-13.05%-153.89M	63.26%-25.26M	68.84%-21.45M	-150.49%-31.67M	-23.17%-75.52M	-179.46%-136.13M	-186.06%-68.74M	-132.40%-68.82M
Net income from continuing operations	-366.37%-127M	-223.78%-135.38M	-18.57%-209.28M	-29.17%-111.02M	-44.53%-104.13M	7.46%47.68M	33.50%-41.81M	-25.31%-176.49M	-35.61%-85.94M	-140.76%-72.05M
Operating gains losses	--0	---80K	----	----	----	----	----	359.48%4.43M	----	----
Depreciation and amortization	69.54%4.53M	58.53%4.26M	19.88%12.49M	45.08%3.86M	26.29%3.28M	2.89%2.67M	4.51%2.69M	26.06%10.42M	6.23%2.66M	29.89%2.59M
Other non cash items	43.27%7.25M	88.38%5.37M	--18.33M	--6.29M	145.13%4.13M	730.38%5.06M	1,117.50%2.85M	----	----	3,401.96%1.68M
Change In working capital	103.15%3.37M	81.67%-10.87M	47.56%-51.55M	517.88%59.44M	237.46%55.25M	-473.48%-106.91M	-135.10%-59.32M	-142.99%-98.29M	-688.78%-14.23M	-105.41%-40.19M
-Change in receivables	--0	--0	-84.06%1.41M	206.40%1.25M	6,225.42%68.19M	-2,459.30%-29.87M	-477.61%-38.16M	194.01%8.85M	87.78%-1.17M	280.92%1.08M
-Change in prepaid assets	-109.15%-895K	-116.60%-1.75M	160.15%11.6M	-56.47%-16.31M	236.91%7.6M	441.60%9.78M	2,439.78%10.53M	-5,258.61%-19.29M	-511.20%-10.42M	-714.37%-5.55M
-Change in payables and accrued expense	132.18%3.64M	-29.97%-12.06M	61.57%18.03M	246.74%45.11M	3.06%-6.49M	-190.35%-11.32M	-20.78%-9.28M	-8.14%11.16M	374.49%13.01M	-141.46%-6.7M
-Change in other current liabilities	----	579.07%3.8M	----	----	----	----	143.04%559K	----	----	----
-Change in other working capital	105.89%4.42M	96.23%-866K	16.58%-82.59M	287.92%29.39M	50.58%-14.06M	-172.68%-74.95M	16.25%-22.98M	-143.75%-99.01M	-210.12%-15.64M	19.47%-28.44M
Cash from discontinued investing activities
Operating cash flow	-191.68%-92.38M	-56.05%-117.84M	-13.05%-153.89M	63.26%-25.26M	68.84%-21.45M	-150.49%-31.67M	-23.17%-75.52M	-179.46%-136.13M	-186.06%-68.74M	-132.40%-68.82M
Investing cash flow
Cash flow from continuing investing activities	-645.70%-268.94M	180.35%64.84M	-1,675.06%-96.16M	-16.29%30.51M	-116.16%-9.91M	48.30%-36.07M	-141.71%-80.69M	96.18%-5.42M	130.82%36.45M	413.59%61.28M
Net PPE purchase and sale	-24.75%-34.08M	-76.44%-68.66M	-234.88%-176.74M	-95.37%-63.91M	-388.73%-46.61M	-474.79%-27.31M	-573.43%-38.91M	-123.94%-52.78M	-298.96%-32.71M	-142.58%-9.54M
Net investment purchase and sale	-2,583.83%-234.86M	419.50%133.5M	70.15%80.58M	36.53%94.42M	-48.17%36.7M	86.54%-8.75M	-51.35%-41.78M	140.10%47.36M	162.84%69.16M	553.65%70.81M
Cash from discontinued investing activities
Investing cash flow	-645.70%-268.94M	180.35%64.84M	-1,675.06%-96.16M	-16.29%30.51M	-116.16%-9.91M	48.30%-36.07M	-141.71%-80.69M	96.18%-5.42M	130.82%36.45M	413.59%61.28M
Financing cash flow
Cash flow from continuing financing activities	82,741.73%430.78M	-99.89%267K	288.20%253.05M	-82.22%152K	-97.02%1.81M	-71.83%520K	13,193.16%250.58M	476.61%65.19M	4.91%855K	2,099.64%60.6M
Proceeds from stock option exercised by employees	190.77%1.51M	-53.65%267K	-41.13%3.05M	-3.98%821K	89.33%1.14M	-71.83%520K	-69.44%576K	-54.13%5.19M	4.91%855K	-78.22%600K
Net other financing activities	----	----	316.67%250M	---669K	--669K	--0	--250M	--60M	--0	----
Cash from discontinued financing activities
Financing cash flow	82,741.73%430.78M	-99.89%267K	288.20%253.05M	-82.22%152K	-97.02%1.81M	-71.83%520K	13,193.16%250.58M	476.61%65.19M	4.91%855K	2,099.64%60.6M
Net cash flow
Beginning cash position	-71.22%58.22M	2.67%110.89M	-41.44%108.01M	-24.46%105.33M	56.19%134.96M	120.83%202.25M	-41.44%108.01M	28.45%184.43M	-57.22%139.44M	-76.80%86.41M
Current changes in cash	203.34%69.46M	-155.88%-52.73M	103.94%3.01M	117.19%5.4M	-155.68%-29.55M	-1,197.61%-67.22M	201.68%94.37M	-286.53%-76.36M	77.78%-31.44M	214.37%53.06M
Effect of exchange rate changes	135.14%26K	147.54%58K	-82.09%-122K	5,000.00%153K	-146.88%-79K	-7,500.00%-74K	-212.82%-122K	23.86%-67K	--3K	---32K
End cash Position	-5.38%127.7M	-71.22%58.22M	2.67%110.89M	2.67%110.89M	-24.46%105.33M	56.19%134.96M	120.83%202.25M	-41.44%108.01M	-41.44%108.01M	-57.22%139.44M
Free cash flow	-114.38%-126.45M	-62.98%-186.5M	-75.02%-330.63M	12.11%-89.16M	13.15%-68.05M	-201.74%-58.99M	-70.57%-114.43M	-227.86%-188.91M	-214.78%-101.45M	-133.60%-78.35M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall